Szabolcs Kertesz

Title: Innovations by Szabolcs Kertesz

Introduction

Szabolcs Kertesz is a notable inventor based in Fót, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in cognitive enhancement and neuroprotection. With a total of 2 patents, his work reflects a commitment to advancing medical science.

Latest Patents

Kertesz's latest patents include a medicament for the enhancement of cognitive function and neuroprotection. This invention involves the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone, or its pharmaceutically acceptable salts, for preparing medicaments aimed at improving cognitive function and providing neuroprotective effects. These medicaments can be utilized in treating or preventing various neurological conditions, including neuronal death, mental decline, and memory disturbances.

Another significant patent by Kertesz involves new 8-chloro-2,3-benzodiazepine derivatives. This invention relates to compounds that possess AMPA/kainate receptor inhibiting activity. The derivatives are characterized by a general formula that includes lower alkyl groups and their pharmaceutically acceptable acid addition salts. The invention also covers the preparation process of these compounds and their pharmaceutical compositions.

Career Highlights

Throughout his career, Szabolcs Kertesz has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár Nyilvánosan Mukodo Részvénytársaság and Egis Gyógyszergyár Rt. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Kertesz has collaborated with notable professionals in his field, including Gabor Gigler and Jozsef Barkoczy. These collaborations have likely enriched his research and development efforts, leading to impactful inventions.

Conclusion

Szabolcs Kertesz is a distinguished inventor whose work in cognitive enhancement and neuroprotection has the potential to significantly impact medical science. His patents reflect a deep understanding of pharmaceutical innovation and a commitment to improving human health.